Post-approval studies (Phase 4)Ended earlyNCT03471117
What this trial is testing
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
Who this might be right for
Chronic Kidney Diseases
The University of Texas at Arlington 5
Showing 20 of 0 results